GalR2 allosteric modulators (NeuroTargets/University of Bristol)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGalR2 allosteric modulators (NeuroTargets/University of Bristol)
Drug Alias Namegalanin modulators (University of Bristol)galanin receptor 2 allosteric modulators (University of Bristol)galanin receptor 2 allosteric modulators (NeuroTargets/University of Bristol)galanin receptor 2 allosteric modulators (NeuroTargets)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalanin receptor type 2 modulators
TargetsGalanin receptor type 2
Therapy Area/IndicationsNeuralgiaAlzheimer DiseaseMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bristol
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuroTargets LtdUniversity Of Bristol
Active IndicationsN/A
Inactive IndicationsNeuralgiaAlzheimer DiseaseMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A